VOLUME TO VALUE — THE EVOLUTION OF MEDICAL DEVICE PROCUREMENT Aligning Value
Learnings from an international procurement roundtable
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Learnings from an international procurement roundtable
By Gabriela Prada, director of Global Health Systems Policy, Global Government Affairs at Medtronic
More than 50 healthcare leaders gathered in January in Barcelona to discuss how procurement is increasingly used to support value-based healthcare (VBHC) efforts.
Value-based procurement (VBP), an approach that involves making purchasing decisions based on overall value (health outcomes, quality, service, and cost) rather than cost alone, is gaining prominence in Europe and delivering on its promise.
...the procurement function is evolving to become a strategic component of innovation and sustainability in healthcare.
Public procurers from 11 countries shared their experiences and provided inspiring examples that demonstrated how procurement is being used as a strategic lever to achieve hospitals’ and health systems’ goals. This reflects how the procurement function is evolving to become a strategic component of innovation and sustainability in healthcare.
Important lessons emerged from the candid discussions among procurement experts, administrators, and clinicians.
No doubt progress is being made in defining and advancing VBP across jurisdictions, but much work remains, starting with a consensus of what constitutes value in the context of medical device procurement.
To steer this conversation, we have suggested a model depicting the evolution of the procurement landscape. In this evolution, the greatest value (better healthcare outcomes) requires a more complex strategy involving new clinical pathways and business models that incorporate devices and services. This model suggests how procurement is moving away from outsourcing towards strong partnerships where public and private sectors are both accountable for better healthcare outcomes. The examples from Catalonia, Denmark, Norway, and Canada shared in Barcelona demonstrated how these partnerships are changing today’s healthcare.
This roundtable left the participants energized and inspired, thanks to the public procurement leaders for sharing their wisdom, representatives of the World Bank, the European Commission and ICHOM for contributing their vision and thoughts, and our partners (AQuAS, University of Zaragoza, and MedTech Europe) for making this event possible.